Reversal of ventricular remodeling: Important to establish and difficult to define

European Journal of Heart Failure

Volumn 9, Issue 4, 2007, Pages 325-328

  Hauptman, Paul J ^a   Sabbah, Hani N ^b  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Heart Failure; Remodeling

Indexed keywords

EDITORIAL; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; MORBIDITY; MORTALITY; PHENOTYPE; PRIORITY JOURNAL;

HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR;

EID: 33947369910     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.09.008     Document Type: Editorial

References (38)

1. Pfeffer J.M., Pfeffer M.A., and Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57 (1985) 84-95
2. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35 (2000) 569-582
3. Zile M.R. Structural components of cardiomyocyte remodeling: summation. J Card Fail 8 Suppl. 6 (2002) S311-S313
4. Spinale F.G. The extracellular matrix: summation. J Card Fail 8 Suppl. 6 (2002) S349-S350
5. Dorin G.W., and Mann D.L. Signaling pathways involved in left ventricular remodeling: summation. J Card Fail 8 Suppl. 6 (2002) S387-S388
6. Konstam M.A., Udelson J.A., and Sharpe N. Prevention and reversal of left ventricular remodeling: summation. J Card Fail 8 Suppl. 6 (2002) S506-S511
7. Udelson J.E., and Konstam M.A. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. J Card Fail 8 Suppl. 6 (2002) S465-S471
8. Greenberg B.H. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials. J Card Fail 8 Suppl. 6 (2002) S486-S490
9. Colucci W.S., and Braunwald E. Atlas of heart failure (1999), Current Medicine Inc, Philadelphia (PA)
10. Australia/New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349 (1997) 375-380
11. Bozkurt B., Torre-Amione G., and Warren M.S. Results of targeted anti-tumor necrosis factor therapy with etanercept in patients with advanced heart failure. Circulation 103 (2001) 1044-1047
12. Barbone A., Holmes J.W., Heerdt P.M., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure. Circulation 104 (2001) 670-675
13. 2+ cycling after left ventricular assist device support in the failing human heart. J Am Coll Cardiol 44 (2004) 837-845
14. Milting H., Jacob M., Kassner A., et al. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devises using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant 23 (2004) 396-404
15. Lowes B.D., Gilbert E.M., Abraham W.T., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346 18 (2002) 1357-1365
16. McCarthy J.F., McCarthy P.M., Starling R.C., et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardio Thor Surg 13 (1998) 337-343
17. Bach D., and Bolling S.F. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Card 78 (1996) 966-969
18. Bax J.J., Braun J., Somer S.T., et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110 suppl II (2004) II-103-II-108
19. Kass D.A., Baughman K.L., Pak P.H., et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation 91 (1995) 2314-2318
20. Mann D.L., Acker M.A., Jessup M., Sabbah H.N., Starling R.C., and Kubo S.H. Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure. J Card Fail 10 (2004) 185-192
21. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
22. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) study. JAMA 283 (2000) 1295-1302
23. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
24. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., and Eichhorn E.J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 25 (1995) 1154-1161
25. Bello D., Shah D.J., Farah G.M., et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108 (2003) 1945-1953
26. Waagstein F., Stromblad O., Andersson B., et al. Increased ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Eur J Heart Fail 5 (2003) 679-691
27. Waagstein F., Gaidahl K., Wallentin I., Bergh C.H., and Hjalmarson A. Long term beta blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80 (1989) 551-563
28. St John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
29. Saxon L.A., De Marco T., Schafer J., Chatterjee K., Kumar U.N., and Foster E. Effects of long term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 105 (2002) 1304-1310
30. Auricchio A., Stellbrink C., Block M., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99 (1999) 2993-3001
31. Woo G.W., Petersen-Stejskal S., Johnson J.W., Conti J.B., Aranda Jr. J.A., and Curtis A.B. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 12 (2005) 107-113
32. Yu C.M., Chau E., Sanderson J.E., et al. Tissue Doppler electrocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105 (2002) 438-445
33. Kerwin W.F., Botvinick E.H., O'Connell W., et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct intraventricular dyssynchrony. J Am Coll Cardiol 35 (2000) 1221-1227
34. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
35. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 352-362
36. Prunier F., Marescaux L., Franconi F., et al. Serial magnetic resonance imaging based assessment of the early effects of an ACE inhibitor on postinfarction left ventricular remodeling in rats. Can J Physiol Pharm 83 (2005) 1109-1115
37. Westenberg J.J., van der Geest R.J., Lamb H.J., et al. MRI to evaluate left atrial and ventricular reverse remodeling after restrictive mitral annuloplasty in dilated cardiomyopathy. Circulation 112 (2005) I437-I442
38. Hombach V., Grebe O., Merkle N., et al. Sequelae of acute myocardial infarctin regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26 (2005) 532-533